Pharma's Almanac

27 Articles Available

0 2

CDMO

Maximizing Outsourcing Benefits for Virtual Pharma Companies

PAO-09-23-CL-08

Aqueous Cleaning

The Power of Aqueous Detergents in Critical Cleaning

PTV-12-23-CL-03

Cell Culture Media

Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products

PAO-08-23-CL-05

Cleanrooms

Design–Build Cleanroom Projects: A Proven Risk Mitigating Methodology

PAO-10-23-CL-06

Sustainability

Green Energy Is Almost Here: A CDMO’s Approach to Sustainability

PAO-09-23-CL-06

Cell and Gene Therapy

View from the Top: Cell and Gene Therapy Successes and Promise

Formulation

Addressing Swallowing and Palatability Issues with Patient-Friendly Dosage Forms

PAO-09-23-CL-04

3D Cell Culture

Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine

PAO-09-23-CL-02

Cell Therapy

Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support

PAO-09-23-CL-09

CDMO

Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market

PAO-08-23-CL-06

Real-World Data

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

PAO-09-23-RT-01

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

PAO-09-23-RT-02

Nitrosamine Impurities

Addressing the Evolving Nitrosamine Contamination Issue

PAO-09-23-CL-07

Data Management

Who is Using FAIR Data in Life Sciences R&D Today?

PAO-09-23-CL-05

Cell Therapy

Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies

PAO-08-23-CL-04

Data Management

Embracing FAIR Data on the Path to AI-Readiness

PAO-09-23-CL-03

Insect Cell Expression

Innovations in Baculovirus–Insect Cell Expression Systems

PAO-09-23-CL-01

Decentralized Clinical Trials

Innovating DCTs Through Application and Cross-Functional Delivery

PAO-07-23-CL-02

Clinical and Commercial Manufacturing

Reach the Patient Quicker with GBI’s Manufacturing Solutions

PAO-08-23-CL-02

New Integrated mRNA Offering

Building on Experience and Investing in an Integrated mRNA Offering

PAO-07-23-CL-03

Risk Management in mRNA Manufacture

Managing Risk in Cutting-Edge mRNA Therapeutics

PAO-07-23-CL-04

Quality Culture

Does Your Biologics CDMO Truly Have a Culture of Quality?

PAO-07-23-CL-07

CMC

The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies

PAO-07-23-CL-05

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

PAO-07-23-RT-01

0 2

Q32023

27 Articles Available

Can't find what you're looking for? Try our advanced search.

CDMO

Maximizing Outsourcing Benefits for Virtual Pharma Companies

Aqueous Cleaning

The Power of Aqueous Detergents in Critical Cleaning

Cell Culture Media

Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products

Cleanrooms

Design–Build Cleanroom Projects: A Proven Risk Mitigating Methodology

Sustainability

Green Energy Is Almost Here: A CDMO’s Approach to Sustainability

Cell and Gene Therapy

View from the Top: Cell and Gene Therapy Successes and Promise

Formulation

Addressing Swallowing and Palatability Issues with Patient-Friendly Dosage Forms

3D Cell Culture

Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine

Cell Therapy

Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support

CDMO

Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market

Real-World Data

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Nitrosamine Impurities

Addressing the Evolving Nitrosamine Contamination Issue

Data Management

Who is Using FAIR Data in Life Sciences R&D Today?

Cell Therapy

Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies

Data Management

Embracing FAIR Data on the Path to AI-Readiness

Insect Cell Expression

Innovations in Baculovirus–Insect Cell Expression Systems

Decentralized Clinical Trials

Innovating DCTs Through Application and Cross-Functional Delivery

Clinical and Commercial Manufacturing

Reach the Patient Quicker with GBI’s Manufacturing Solutions

New Integrated mRNA Offering

Building on Experience and Investing in an Integrated mRNA Offering

Risk Management in mRNA Manufacture

Managing Risk in Cutting-Edge mRNA Therapeutics

Quality Culture

Does Your Biologics CDMO Truly Have a Culture of Quality?

CMC

The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?